bit.bio

Cambridge biotech making human cell models, engineered from reprogrammed cells for drug discovery and research.

View on the globe

$25MEquity raised in 2025–20262025 — · 2026 $25M · 1 equity round
$25MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 4 Nov 2026 to 4 Nov 2026, $25M equity disclosed. Earlier rounds exist but are not sourced.4 Nov 2026: Series D, $25M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yet← earlier rounds not sourcedQ2Q3Q42027Q2Q3Equity round4 Nov 2026 · Series D · $25MSeries D · $25M
Funding history: 1 round from 4 Nov 2026 to 4 Nov 2026, $25M equity disclosed. Earlier rounds exist but are not sourced.4 Nov 2026: Series D, $25M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yetearlier rounds not sourcedQ3Q42027Q2Q3Equity round4 Nov 2026 · Series D · $25M$25M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. bit.bio raised before 4 Nov 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series D
    Amount$25M
    Post-money—
    ✓ Confirmed
    Also
    M&G Investments, Jonathan Milner
    Note
    Company release (4 Nov 2026, 'bit.bio secures $25 million as demand ... reaches record levels'): 'has secured $25 million in Series D funding'. Treated as a closed round (release announces funds secured; the word 'closed' is not used). Release names existing investor M&G Investments and Dr Jonathan Milner (founder and former CEO of Abcam) as backers; no lead labelled. Pre/post-money not stated. An earlier USD 50M round with M&G (2026-01-12) was not found on the company newsroom and is not recorded. Founding year not stated. Earlier rounds not sourced (historyComplete=false).
    Sources
  2. Earlier rounds not yet sourced

Investors 2

  • Jonathan Milner
  • M&G Investments

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the Cambridge hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. bit.bio and its logo are trademarks of their owners, used here for identification only.